The global infusion drug delivery market continues to be driven by the rising prevalence of chronic disease and associated obesity, coupled with a growing aging population. Technological advancements such as less invasive pumps, needlestick prevention features and miniaturization have also supported the growing demand, but obstacles such as safety and security issues remain. According to a new report by Meddevicetracker, the global market for infusion pumps and disposables will reach $9.9bn by 2022, a CAGR of 6.4% from 2017. This article takes an in-depth look at the overall infusion pumps market, and dives deeper into the three fastest-growing segments – insulin, enteral and disposable pumps – highlighting the key players and competitive landscape.
Used in a wide range of applications, infusion pumps are a staple in a hospital's inventory but these devices are also used in increasingly varied settings such as ambulatory centers, physician offices and clinics and patients' homes. According to a new report by Meddevicetracker, the global market for infusion pumps and associated disposables is expected to grow from $7.2bn in 2017 to $9.9bn by 2022, a CAGR of 6.4%.
The report covers seven types of infusion pumps: volumetric, syringe, ambulatory, disposable, implantable, insulin and enteral pumps
